Showing 8131-8140 of 20420 results for "".
Addressing Barriers to CAR T Referral in R/R LBCL
https://reachmd.com/programs/project-oncology/barriers-car-t-referral-rr-lbcl/56467/This is a non-certified educational series produced and controlled by ReachMD. Timely referral for CAR T-cell therapy remains a critical challenge for patients with relapsed or refractory large B-cell lymphoma (R/R LBCL). From communication gaps between providers to logistical challenges and delays,Multiple Sclerosis Without Borders: Taking a Global View
https://reachmd.com/programs/neurofrontiers/multiple-sclerosis-without-borders-taking-a-global-view/54237/Multiple sclerosis (MS) is now being recognized as a global disease shaped by a combination of genetics, environment, and social determinants of health—and not one just limited to northern latitudes or people of European descent. However, disparities in awareness, diagnostic resources, and access toUpdates in Undifferentiated Eczema: Taking a Practical Approach to Care
https://reachmd.com/programs/clinicians-roundtable/updates-in-undifferentiated-eczema-taking-a-practical-approach-to-care/32390/Here’s a quick summary of a session on undifferentiated eczema that was presented at the Maui Derm 2025 conference.Communicating Pathologic Response Results in Resectable NSCLC
https://reachmd.com/programs/project-oncology/communicating-pathologic-response-resectable-nsclc/49116/How can multidisciplinary teams effectively communicate pathologic response findings to patients with non-small cell lung cancer (NSCLC) following surgery? To find out, Dr. Charles Turck speaks with Drs. Alexander Spira and Robert Merritt, who each share practical strategies for explaining pathologyAdvances in DMD Care: Evaluating a Gene Therapy’s Efficacy and Safety
https://reachmd.com/programs/neurofrontiers/advances-in-dmd-care-evaluating-a-gene-therapys-efficacy-and-safety/26327/Explore the efficacy and safety data that led to the expanded approval of a gene therapy for patients with Duchenne muscular dystrophy.Predicting the Development of Food Allergies with Skin Biomarkers
https://reachmd.com/programs/frontlines-food-allergies/predicting-the-development-of-food-allergies-with-skin-biomarkers/18015/Tune in to find out how skin biomarkers can predict the development of food allergies based on findings from a recent study.Helping Patients Prioritize Health and Wellness
https://reachmd.com/programs/what-your-patients-are-talking-about/helping-patients-prioritize-health-and-wellness/15488/Why should patients exercise? Tune in.Trimethylamine N-Oxide and CKD: A Concerning Link
https://reachmd.com/programs/clinicians-roundtable/trimethylamine-n-oxide-and-ckd-a-concerning-link/24123/How might trimethylamine N-oxide contribute to the development and progression of CKD? Find out with this recap of a recent study.Addressing Health Equity in Genitourinary Cancer Clinical Trials
https://reachmd.com/programs/project-oncology/addressing-health-equity-in-genitourinary-cancer-clinical-trials/16288/Can addressing the health equity gaps in GU cancer clinical trials help to advance patient care? Dive in.Bits from "Bullets and Brains": Taking the Sting out of Scorpion Venom
https://reachmd.com/programs/book-club/bits-bullets-and-brains-taking-sting-out-scorpion-venom/10692/About one in four children under the age of 5 die from a scorpion sting if they’re not treated. Fortunately, this life-saving antivenom is available.